trial · primary record
Lutetium Lu 177-Edotreotide
Somatostatin Receptor Positive
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2034-04 |
| Primary endpoint | Pediatric Dosage |
| Registry ID | NCT06441331 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:12.846Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06441331
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.